Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-22-037998
Filing Date
2022-03-25
Accepted
2022-03-25 14:15:57
Documents
14
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2210314d1_10ka.htm   iXBRL 10-K/A 150711
2 EXHIBIT 31.1 tm2210314d1_ex31-1.htm EX-31.1 11494
3 EXHIBIT 32.1 tm2210314d1_ex32-1.htm EX-32.1 5221
  Complete submission text file 0001104659-22-037998.txt   386335

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cbdy-20211231.xsd EX-101.SCH 3051
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbdy-20211231_lab.xml EX-101.LAB 35941
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbdy-20211231_pre.xml EX-101.PRE 23630
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2210314d1_10ka_htm.xml XML 5789
Mailing Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9
Business Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9 905-541-3833
Target Group Inc. (Filer) CIK: 0001586554 (see all company filings)

EIN.: 463610035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-55066 | Film No.: 22770360
SIC: 2833 Medicinal Chemicals & Botanical Products